Insulet (PODD) Receivables - Other (2018 - 2023)

Insulet (PODD) has reported Receivables - Other for 6 consecutive years, with $57.6 million the latest figure, recorded in Q1 2023.

• For the quarter ending Q1 2023, Receivables - Other rose 60.89% year-over-year to $57.6 million; the trailing twelve-month figure through Mar 2023 stood at $57.6 million (up 60.89% YoY), and the FY2022 full-year result was $64.7 million, up 150.78% from the prior year.
• Receivables - Other fell to $57.6 million in Q1 2023 per PODD's latest filing, from $64.7 million in the prior quarter.
• Across five years, Receivables - Other topped out at $64.7 million in Q4 2022 and bottomed at $9.5 million in Q1 2019.
• Historically, Receivables - Other has averaged $27.0 million across 5 years, with a median of $17.3 million in 2021.
• The sharpest annual moves came in 2021 and 2022: Receivables - Other slipped 19.28% in 2021, then surged 200.0% in 2022.
• Over 5 years, Receivables - Other stood at $13.5 million in 2019, then fell by 14.07% to $11.6 million in 2020, then jumped by 122.41% to $25.8 million in 2021, then jumped by 150.78% to $64.7 million in 2022, then dropped by 10.97% to $57.6 million in 2023.
• According to Business Quant data, Receivables - Other over the past three periods registered $57.6 million, $64.7 million, and $48.3 million for Q1 2023, Q4 2022, and Q3 2022 respectively.